Clinical Studies Search

Protocol Search Results


Protocol No. Title
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12
PSCI-17-059 Communication Preferences Related to Over Screening for Cancer Among Older Adults
PSCI-17-068 FORCE: Focus on Reducing Dose-Limiting Toxicities in Colon Cancer with Resistance Exercise
PSCI-17-070 Maintenance Obinutuzumab for primary central nervous system lymphoma complete responders
PSCI-17-072 HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors Clinical and Molecular Risk-Tailored Intensive and Compressed Induction Chemotherapy Followed by Consolidation With Randomization to Either Single Cycle or to Three Tandem Cycles of Marrow-Ablative Chemotherapy With Autologous Hematopoietic Progenitor Cell Rescue
PSCI-17-075 A Phase 2, Prospective, Randomized, Open-label Study on the Efficacy of Defibrotide Added to Standard of Care Immunoprophylaxis for the Prevention of Acute Graft-versus-Host-Disease in Adult and Pediatric Patients After Allogeneic Hematopoietic Stem Cell Transplant
PSCI-17-076 LEAHRN (Late Effects After High-Risk Neuroblastoma) Study
PSCI-17-080 A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (IND# 133688, NSC# 102816) to Chemotherapy in Infants with Acute Lymphoblastic Leukemia (ALL) and KMT2A (MLL) Gene Rearrangement
PSCI-17-081 A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors
PSCI-17-084 Imaging and Mobile Assessments of Cognition, Environment, and Sleep Study
PSCI-17-087 A Phase 1b/2 study to assess the safety, tolerability and efficacy of BGB-290 in combination with radiation therapy and/or temozolomide in subjects with first-line or recurrent/refractory glioblastoma